Antje Beling Selected Research

Myocarditis (Carditis)

1/2021	Mitigated viral myocarditis in A/J mice by the immunoproteasome inhibitor ONX 0914 depends on inhibition of systemic inflammatory responses in CoxsackievirusB3 infection.
1/2021	Exploration of Analgesia with Tramadol in the Coxsackievirus B3 Myocarditis Mouse Model.
1/2020	Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
1/2020	Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
1/2020	ONX 0914 Lacks Selectivity for the Cardiac Immunoproteasome in CoxsackievirusB3 Myocarditis of NMRI Mice and Promotes Virus-Mediated Tissue Damage.
11/2019	Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
1/2018	Proteasomal Protein Degradation: Adaptation of Cellular Proteolysis With Impact on Virus-and Cytokine-Mediated Damage of Heart Tissue During Myocarditis.
1/2018	The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis.
1/2018	The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis.
1/2018	Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antje Beling Research Topics

Disease

13	Infections 02/2024 - 01/2018
11	Myocarditis (Carditis) 01/2021 - 01/2017
6	Inflammation (Inflammations) 01/2021 - 01/2018
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Cicatrix (Scar) 01/2020 - 11/2019
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Heart Diseases (Heart Disease) 01/2018 - 01/2018
1	Atrophy 02/2024
1	Moyamoya Disease (Moya-Moya Disease) 10/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021
1	Pancreatitis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 11/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 11/2019
1	Sepsis (Septicemia) 01/2018

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2018
5	CytokinesIBA 01/2020 - 01/2018
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021 - 01/2017
4	PR-957IBA 01/2021 - 01/2018
3	EnzymesIBA 02/2024 - 11/2019
2	Cysteine (L-Cysteine)FDA Link 01/2022 - 01/2018
2	UbiquitinsIBA 11/2021 - 10/2021
2	InterferonsIBA 11/2021 - 10/2021
2	Antiviral Agents (Antivirals)IBA 01/2020 - 11/2019
2	ChemokinesIBA 01/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 11/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2017
1	HexokinaseIBA 02/2024
1	PhosphofructokinasesIBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Interferon Type IIBA 02/2024
1	Adenosine Triphosphate (ATP)IBA 02/2024
1	Alanine (L-Alanine)FDA Link 01/2022
1	UbiquitinIBA 11/2021
1	Blocking AntibodiesIBA 01/2021
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Tramadol (K315)FDA LinkGeneric 01/2021
1	Troponin IIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	PolyubiquitinIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Virus ReceptorsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	adenovirus receptorIBA 11/2019
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018

Therapy/Procedure

2	Therapeutics 01/2020 - 11/2019
1	Analgesia 01/2021